(76 days)
The ATLANTIS® Conus Structure is indicated for attachment to ATLANTIS® Conus abutment, Overdenture (OD) via prefabricated SynCone 5° Taper caps (Degulor®) in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.
The ATLANTIS® Conus Structure is intended for conical attachment to a minimum of four (4) ATLANTIS® Conus abutments, Overdenture (OD). The ATLANTIS® Conus Structure is only intended for acrylic or composite veneering.
The proposed ATLANTIS® Conus structure is a patient-specific endosseous dental implant support structure that is indicated for attachment to dental abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.
The design of the proposed device is derived from patient dental models and completed by Dentsply Sirona technicians using computer-assisted design (CAD) according to the clinician's prescription. The final CAD design of the ATLANTIS® Conus Structure is fabricated using additive manufacturing to produce a customized, patient-specific device.
The proposed ATLANTIS® Conus Structure is available in the following design types:
- ATLANTIS® Conus Bridge Intended for direct veneering using dental resin composites resulting in a removable friction-retained prosthesis. The bridge provides a full anatomical base for composite layering techniques.
- ATLANTIS® Conus Hybrid Intended as a removable friction-retained denture framework. The hybrid variant provides a surface with retention elements that can be finished with resin-based denture prosthesis.
- ATLANTIS® Conus Base Intended as a removable friction-retained denture framework for finishing with the resin-based denture prosthesis.
The provided text describes the ATLANTIS® Conus Structure, a dental device, and its substantial equivalence to predicate devices, rather than a study proving the device meets specific acceptance criteria in the context of diagnostic accuracy or clinical effectiveness with human readers or ground truth established by experts.
The document is a 510(k) summary for a medical device, which focuses on demonstrating substantial equivalence to a legally marketed predicate device, primarily through non-clinical performance data and technological characteristics comparison. It does not contain information about a clinical study with acceptance criteria for diagnostic performance, human reader improvement, or ground truth established by experts.
However, I can extract the acceptance criteria and performance data for the non-clinical performance tests described:
1. Table of Acceptance Criteria and Reported Device Performance
| Test Type | Acceptance Criteria | Reported Device Performance |
|---|---|---|
| Dynamic Fatigue Tests | Based on ISO 14801 Dentistry - Implants - Dynamic fatigue test for endosseous dental implants | Implicitly met: "non-clinical performance test data are included to support substantial equivalence" and "Performance testing has been conducted... to verify that the subject device meets its predetermined performance requirements and the results support a conclusion of substantial equivalence." (Specific quantitative results are not provided in this summary.) |
| Bond Strength (SynCone® 5° Taper caps and ATLANTIS® Conus Structure) | Verify bond strength when subjected to pull-off loads. | Implicitly met: "Testing in order to verify the bond strength... when subjected to pull-off loads." (Specific quantitative results are not provided in this summary.) |
| Dimensional Verification Analysis (Conical Connection Cavities) | Ensure correct fit with SynCone® 5° Taper caps (Degulor®). | Implicitly met: "Dimensional verification analysis... to ensure correct fit with SynCone® 5° Taper caps (Degulor®)." (Specific quantitative results are not provided in this summary.) |
2. Sample size used for the test set and the data provenance
The document does not specify the sample sizes for the non-clinical performance tests (dynamic fatigue, bond strength, dimensional verification). The data provenance is internal testing performed by Dentsply Sirona. These are prospective tests designed to evaluate the physical properties of the device.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable. This device is not a diagnostic tool requiring expert interpretation or ground truth establishment in a clinical sense. The "ground truth" here pertains to engineering specifications and performance standards outlined in ISO 14801 and internal Dentsply Sirona testing protocols.
4. Adjudication method for the test set
Not applicable. The tests are mechanical and dimensional, not requiring expert adjudication of results. The results are typically compared against pre-defined engineering specifications.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This is a physical dental implant component, not an AI-assisted diagnostic device.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is a physical dental implant component, not an algorithm.
7. The type of ground truth used
For the non-clinical performance tests, the "ground truth" refers to established engineering standards (e.g., ISO 14801) and internal design specifications for mechanical strength, bond strength, and dimensional accuracy.
8. The sample size for the training set
Not applicable. The device is a physical product, not an AI model requiring a training set. The design and manufacturing processes are iterative but do not involve "training data" in the AI sense.
9. How the ground truth for the training set was established
Not applicable, as there is no "training set" for this physical device. The design and manufacturing parameters are established through engineering principles, material science, and prior regulatory clearances of similar devices.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is a blue square with the letters "FDA" in white. To the right of the square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
July 18, 2018
Dentsply Sirona Karl Nittinger Director, Corporate Regulatory Affairs 221 W Philadelphia Street. Suite 60W York, Pennsylvania 17401
Re: K181189
Trade/Device Name: ATLANTIS® Conus Structure Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: Class II Product Code: NHA Dated: May 1, 2018 Received: May 3, 2018
Dear Karl Nittinger:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Andrew I. Steen -S
for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known)
K181189
Device Name ATLANTIS® Conus Structure
Indications for Use (Describe)
The ATLANTIS® Conus Structure is indicated for attachment to ATLANTIS® Conus abutment, Overdenture (OD) via prefabricated SynCone 5° Taper caps (Degulor®) in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.
The ATLANTIS® Conus Structure is intended for conical attachment to a minimum of four (4) ATLANTIS® Conus abutments, Overdenture (OD). The ATLANTIS® Conus Structure is only intended for acrylic or composite veneering.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW .
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
EF
{3}------------------------------------------------
Dentsply Sirona 221 West Philadelphia Street Suite 60 York, PA 17404
Image /page/3/Picture/2 description: The image contains the logo for Dentsply Sirona. The logo consists of a stylized leaf-like shape on the left, followed by the text "Dentsply" on the top line and "Sirona" on the bottom line. The text is in a simple, sans-serif font and is aligned to the right of the leaf-like shape.
SECTION 5. 510(k) SUMMARY
for
ATLANTIS® Conus Structure
-
- Submitter Information:
Dentsply Sirona 221 West Philadelphia Street Suite 60W York, PA 17401
- Submitter Information:
| Contact Person: | Karl Nittinger |
|---|---|
| Telephone Number: | 717-849-4424 |
| Fax Number: | 717-849-4343 |
Date Prepared: 17-July-2018
-
- Device Name:
- Proprietary Name: ATLANTIS® Conus Structure .
- Classification Name: Endosseous dental implant abutment. ●
Class II
- . CFR Number: 21 CFR 872.3630
- Device Class: ●
- . Product Code: NHA (Abutment, Implant, Dental Endosseous)
-
- Predicate Device:
The predicate and reference devices that have been identified relating to the substantial equivalence of the ATLANTIS® Conus Structure are:
| Predicate Device Name | 510(k) | Company Name |
|---|---|---|
| ATLANTIS™ Suprastructures | K163398 | Dentsply Sirona |
| Reference Device Name | 510(k) | Company Name |
| OsseoSpeed™ Profile EV | K130999 | Dentsply Sirona |
| ATLANTIS™ Abutment for NobelActive 3.0 | K151039 | Dentsply Sirona |
| ATLANTIS™ Abutment for HIOSSEN ET implant | K160626 | Dentsply Sirona |
| ATLANTIS™ Abutment for CONELOG implant | K161030 | Dentsply Sirona |
| ATLANTIS™ Abutment for MIS implant | K172225 | Dentsply Sirona |
| ANKYLOS® SynCone® Abutment 5° | K131644 | Dentsply Sirona |
{4}------------------------------------------------
4. Description of Device:
The proposed ATLANTIS® Conus structure is a patient-specific endosseous dental implant support structure that is indicated for attachment to dental abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.
The design of the proposed device is derived from patient dental models and completed by Dentsply Sirona technicians using computer-assisted design (CAD) according to the clinician's prescription. The final CAD design of the ATLANTIS® Conus Structure is fabricated using additive manufacturing to produce a customized, patient-specific device.
The proposed ATLANTIS® Conus Structure is available in the following design types:
-
- ATLANTIS® Conus Bridge Intended for direct veneering using dental resin composites resulting in a removable friction-retained prosthesis. The bridge provides a full anatomical base for composite layering techniques.
-
- ATLANTIS® Conus Hybrid Intended as a removable friction-retained denture framework. The hybrid variant provides a surface with retention elements that can be finished with resin-based denture prosthesis.
-
- ATLANTIS® Conus Base Intended as a removable friction-retained denture framework for finishing with the resin-based denture prosthesis.
-
- Indications for Use:
ATLANTIS® Conus Structure is indicated for attachment to ATLANTIS® Conus Abutment, Overdenture (OD) via prefabricated SynCone® 5° Taper caps (Degulor®) in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.
The ATLANTIS® Conus Structure is intended for conical attachment to a minimum of four (4) ATLANTIS® Conus abutments, Overdenture (OD). The ATLANTIS® Conus Structure is only intended for acrylic or composite veneering.
- Substantial Equivalence 6.
Technological Characteristics
An overview of the similarities and differences between the proposed and predicate device is given in Table 1: Similarities and Differences between the proposed and the predicate device.
The subject ATLANTIS® Conus Structures are manufactured using the same materials (titanium alloy) and are produced using the identical additive manufacturing processes as are the primary predicate ATLANTIS™ Suprastructures (K163398) devices.
The proposed ATLANTIS® Conus Structure features the same design variants (Bridge and Hybrid) as the predicate device ATLANTIS™ Suprastructures (K163398). In addition to the Bridge and Hybrid variants, the proposed ATLANTIS® Conus Structure also features
{5}------------------------------------------------
the ATLANTIS® Conus Base variant which is a more basic version of the Hybrid as it does not have teeth retention elements on its surface nor the optional extra retention surface profile.
Additionally, the proposed ATLANTIS® Conus Structures which are the subject of this premarket notification feature the same options related to surface profile characteristics as do predicate ATLANTIS™ Suprastructures cleared in K163398. The optional cell retention and pin retention surface profiles of both the subject (with the exception of the subject device's "base" variant) and predicate devices are intended to enhance the surface area available for the mechanical retention of prosthetic materials that are applied to the underlying structures.
With respect to fundamental technology, the subject ATLANTIS® Conus Structures are identical to the primary predicate, the ATLANTIS™ Suprastructures (K163398), with the exception of the interface between the abutment / implant. The proposed ATLANTIS® Conus Structure is a removable structure (friction retained), while the predicate ATLANTIS™ Suprastructures (K163398) is a fixed structure (screw-retained).
While the primary predicate device (K163398) features pre-manufactured, implantspecific interface geometries to facilitate screw-retained connection to implants and abutments, the subject ATLANTIS® Conus Structures are intended for attachment to ATLANTIS® Conus abutments, Overdenture (OD) by friction retention via the currently marketed SynCone 5° Taper caps (Degulor®). The SynCone 5° Taper caps, cleared under reference device K131644, are cemented into recesses in the subject ATLANTIS® Conus Structures and facilitate the tapered friction-fit connection to the conical shape of the ATLANTIS™ Conus Abutment reference devices. The ATLANTIS™ Conus Abutment reference devices are specifically cleared for use with the SynCone 5° Taper caps for tapered friction-fit retention of removable prostheses in their clearances under K130999, K151039, K160626, and K172225. All technologies incorporated in the subject ATLANTIS® Conus Structures have been previously 510(k)-cleared; with the intended use and fundamental technologies cleared in the primary predicate device (K163398) and the tapered friction-fit method cleared in the reference devices, as listed in Section 3 of this 510(k) Summary.
Indications for Use Comparison
The difference in implant / abutment connection method between the subject ATLANTIS® Conus Structures and the primary predicate ATLANTIS™ Suprastructures (K163398) is reflected in the indications for use of the two devices. Because the connection method incorporated in the primary predicate device (K163398) is fixed (i.e., screw retention) and the connection geometries are manufactured to accommodate connection to specific implant and abutment systems, the indications for use of the primary predicate device (K163398) includes an overview of all implant and abutment systems. This is not applicable to the indications for use of the ATLANTIS® Conus Structures due to the fact that all of the ATLANTIS™ Conus Abutment reference devices, to which the subject
{6}------------------------------------------------
ATLANTIS® Conus Structures are friction-retained, feature the same, conical taper geometry which is compatible with the 5° internal taper of the SynCone® caps.
7. Non-Clinical Performance Data
Performance testing
For the proposed ATLANTIS® Conus Structure, non-clinical performance test data are included to support substantial equivalence:
- -Dynamic fatigue tests on worst case test samples of the proposed ATLANTIS® Conus Structures, based on ISO 14801 Dentistry - Implants - Dynamic fatigue test for endosseous dental implants
- -Testing in order to verify the bond strength of the SynCone® 5° Taper caps (Degulor®) and the ATLANTIS® Conus Structure when subjected to pull-off loads.
- -Dimensional verification analysis of the conical connection cavities of the proposed ATLANTIS® Conus Structures to ensure correct fit with SynCone® 5° Taper caps (Degulor®).
Sterilization
The recommended sterilization method and validated sterilization parameters for the subject ATLANTIS® Conus Structures are identical to the sterilization method and validated parameters recommended for the primary predicate device (K163398). Therefore, no new summary sterilization validation information has been included to support substantial equivalence.
Biocompatibility
Because the subject ATLANTIS® Conus Structures are composed of the identical titanium alloy material and are manufactured utilizing the identical additive manufacturing processes, equipment, and process controls of the primary predicate device (K163398) no new biocompatibility testing has been included to support substantial equivalence.
An analysis was conducted to assess the potential for toxicological effects resulting from the interaction of materials. The results of the analysis concluded that, under worst-case conditions, no corrosion products of toxicological concern are released and thus support the biocompatibility and the substantial equivalence of the subject ATLANTIS® Conus Structures.
Clinical Performance Data 8.
No clinical performance data were submitted in support of substantial equivalence.
9. Conclusion Regarding Substantial Equivalence
The proposed ATLANTIS® Conus Structure is intended to be used by dental clinicians in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function. The proposed ATLANTIS® Conus Structure has the same intended use, is composed of the same material, incorporates the same product and manufacturing
{7}------------------------------------------------
technology and has similar indications for use as the predicate device ATLANTIS™ Suprastructures (K163398).
Performance testing has been conducted and is included in this premarket notification to verify that the subject device meets its predetermined performance requirements and the results support a conclusion of substantial equivalence.
{8}------------------------------------------------
| Table 1: Similarities and Differences between the proposed and predicate devices | ||||
|---|---|---|---|---|
| Proposed deviceATLANTIS® Conus Structures | Predicate deviceATLANTISTM Suprastructures(K163398) | Reference DeviceANKYLOS® SynCone® Abutment 5°(K131644) | ||
| Indications foruse | ATLANTIS® Conus Structure is indicated for attachmentto ATLANTIS® Conus Abutment, Overdenture (OD) viaprefabricated SynCone® 5° Taper caps (Degulor®) in thetreatment of partially or totally edentulous jaws for thepurpose of restoring chewing function.The ATLANTIS® Conus Structure is intended for conicalattachment to a minimum of four (4) ATLANTIS® Conusabutments, Overdenture (OD). The ATLANTIS® ConusStructure is only intended for acrylic or compositeveneering. | ATLANTISTM Suprastructures are indicated for attachment to dentalimplants or abutments in the treatment of partially or totallyedentulous jaws for the purpose of restoring chewing function.ATLANTISTM Suprastructures are intended for attachment to aminimum of two (2) implants and are indicated for compatibilitywith the following implant and abutment systems:Implants:• Biomet 3i Certain 3.25, 4/3 - Prevail 3/4/3, 4/3• Biomet 3i Certain 4.0, 5/4 - Prevail 4/5/4, 5/4• Biomet 3i Certain 5.0,XP4/5 - Prevail 5/6/5, 6/5• Biomet 3i Certain 6.0, XP 5/6• BioHorizons Internal/Tapered 3.5, 4.5, 5.7• Camlog Screw-line Implant 3.3• Camlog Screw-line / Root-line Implant 3.8, 4.3, 5.0, 6.0• DENTSPLY Implants XiVE S 3.0, S 3.4, S 3.8, S 4.5, S 5.5• DENTSPLY Implants OsseoSpeed™ TX 3.0, 3.5/4.0, 4.5/5.0• DENTSPLY Implants OsseoSpeed™ Profile TX 4.5/5.0• DENTSPLY Implants OsseoSpeed™ EV 3.0, 3.6, 4.2, 4.8, 5,4• DENTSPLY Implants OsseoSpeed™ Profile EV 4.2, 4.8• Keystone Dental PrimaConnex SD 3.3/3.5• Keystone Dental PrimaConnex RD 4.0/4.1• Keystone Dental PrimaConnex WD 5.0• Keystone Dental Genesis 3.8, 4.5, 5.5/6.5• Nobel Biocare NobelActive NP 3.5 - RP 4.3, 5.0• Nobel Biocare NobelReplace NP 3.5 - RP 4.3 - WP 5.0 - 6.0• Straumann Bone Level 3.3 NC - 4.1, 4.8 RC• Straumann Standard Plus 3.5 NN• Straumann Standard/Standard Plus 4.8 RN - 4.8 WN• Zimmer Dental Tapered S-V 3.5/ S-V 3.3, 3.7 / S-V 4.5/ S-V 4.5• Zimmer Dental Tapered Screw-Vent 5.7Abutments:• Biomet 3i Low Profile Abutment• DENTSPLY Implants ATIS Uni Abutment EV• DENTSPLY Implants ATIS UniAbutment 20°, ATIS UniAbutment 45°• DENTSPLY Implants ATIS Angled Abutment EV,ATIS Angled Abutment 20°• DENTSPLY Implants ANKYLOS Balance Base Narrow D4.2, BalanceBase D5.5• DENTSPLY Implants XIVE MP 3.4, MP 3.8, MP 4.5, MP 5.5• DENTSPLY Implants XiVE TG 3.4, TG 3.8, TG 4.5• Nobel Biocare Multi-Unit Abutment RP• Straumann Bone Level Multi-Base Angled Abutment• Straumann Bone Level Multi-Base Abutment D3.5, D4.5• Straumann RN Abutment Level, WN Abutment Level• Straumann Screw-Retained Abutment 3.5, 4.6• Zimmer Dental Tapered Abutment | SynCone® Abutments on osseointegratedimplants:Anchorage of dentures retained by taperfriction and supported by ANKYLOS®implants.SynCone® Abutments for immediateloading:Immediate loading of an implant supportedprosthesis in an edentulous mandiblesupported by 4 ANKYLOS® implants of atleast 11 mm in length and placedinterforaminally. | |
| Table 1 (continued): Similarities and Differences between the proposed and predicate devices | ||||
| Proposed deviceATLANTIS® Conus Structures | Predicate deviceATLANTISTM Suprastructures(K163398) | Reference DeviceANKYLOS® SynCone®Abutment 5°(K131644) | Summary of Differences | |
| Design | ||||
| Restoration | Multi-unit | Multi-unit | Multi-unit | No differences. |
| Design Type | Hybrid, Bridge, Base | Hybrid, Bridge | Individual endosseous dental implantabutments. | The proposed device is offered in a "base" variant,not offered in the predicate device. The "base"variant is identical to the hybrid variant withexception that it does not feature retention pins andis not offered with the mechanical retention surfaceprofile. The reference devices (K131644) arestandardized endosseous dental implant abutmentswhich are included in relation to their use with theSynCone® 5° taper caps to facilitate frictionretention of prosthetic restorations. |
| ProsthesisAttachment | Friction-retained via 5° SynCone® caps. | Screw-retained | Friction-retained via 5°SynCone® caps. | Predicate device (K163398) incorporates implantsystem-specific interface geometry to facilitatescrew retention with implants. Proposed device doesnot interface directly with implants, instead, as doesthe reference device (K131644), relies on taperfriction fit with currently marketed Conus abutmentsvia currently marketed SynCone® caps. |
| DesignTechnology | CAD/CAM (Additive Manufacturing) | CAD/CAM (AdditiveManufacturing) | Standardized abutment design. | No differences between proposed andpredicate devices. The reference devices(K131644) are standardized endosseous dentalimplant abutments which are included in relation totheir use with the SynCone® 5° taper caps tofacilitate friction retention of prosthetic restorations. |
| Mechanicalretentionsurface featureoptions | No retention (Base, Bridge, and Hybrid)Cell retention (Hybrid)Pin retention (Bridge and Hybrid) | No retention (Bridge and Hybrid)Cell retention (Hybrid)Pin retention (Bridge and Hybrid) | Not applicable. | No differences between the proposed deviceand predicate device. The reference devices(K131644) are standardized endosseous dentalimplant abutments which are included in relation totheir use with the SynCone® 5° taper caps tofacilitate friction retention of prosthetic restorations. |
| Material | ||||
| Material | Titanium alloy | Titanium alloy, CoCr | Titanium alloy | While the predicate device (K163398) was clearedin both Ti alloy and CoCr materials, the proposeddevice is available in Ti alloy material only. |
{9}------------------------------------------------
{10}------------------------------------------------
| Table 2: Summary comparison of ATLANTIS® Conus Structures and Reference Devices | ||||||
|---|---|---|---|---|---|---|
| Proposed Device | Reference Devices | |||||
| Dentsply SironaATLANTIS® ConusStructure | Dentsply SironaOsseoSpeed™ ProfileEV(K130999) | Dentsply SironaATLANTIS™ Abutmentfor NobelActive 3.0(K151039) | Dentsply SironaATLANTIS™ Abutment forHIOSSEN ET implant(K160626) | Dentsply SironaATLANTIS™ Abutment forCONELOG implant(K161030) | Dentsply SironaATLANTIS™ Abutment for MISImplant(K172225) | Summary of Differences |
| Design | ||||||
| Prosthesis Attachment | ||||||
| Friction fit | Friction fitScrew-retainedCement-retained | Friction fitScrew-retainedCement-retained | Friction fitScrew-retainedCement-retained | Friction fitScrew-retainedCement-retained | Friction fitScrew-retainedCement-retained | Fundamentally, no difference.Both the proposed ATLANTIS®Conus Structures and the referencedevices incorporate friction fitattachment and, to facilitate thisfriction fit attachment, theproposed and reference devicesutilize the currently marketedSynCone® tapered caps. |
| Restoration | ||||||
| Multi-unit | Multi-unitSingle unit | Multi-unit.Single unit. | Multi-unit.Single unit. | Multi-unit.Single unit. | Multi-unit.Single unit. | Fundamentally, no difference. Thereference devices may be used forsingle-tooth prosthetic restoration,but also may be used in support ofmulti-unit prostheses via theirATLANTIS® Conus Abutmentvariants using the SynCone® caps. |
| Abutment Platform Diameter (mm) | ||||||
| N/A | 3.0, 4.3, 5.0 | 3.0 | 3.5, 4.0, 4.5, 5.0, 6.0, 7.0 | 3.3, 3.8, 4.3, 5.0 | 3.3, 3.75, 4.2, 5.0, 6.0 | This design element is notapplicable to the proposedATLANTIS® Conus Structures. |
| Abutment angulation | ||||||
| N/A | 0° - 30° | 0° - 30° | 0° - 30° | 0° - 30° | 0° - 30° | This design element is notapplicable to the proposedATLANTIS® Conus Structures. |
| Implant Connection Type | ||||||
| N/A | Internal | Internal | Internal | Internal | Internal | This design element is notapplicable to the proposedATLANTIS® Conus Structures. |
| Table 2 (continued): Summary comparison of ATLANTIS® Conus Structures and Reference Devices | ||||||
| Proposed Device | Reference Devices | Summary of Differences | ||||
| Dentsply SironaATLANTIS® ConusStructure | Dentsply SironaOsseoSpeed™ ProfileEV(K130999) | Dentsply SironaATLANTIS™ Abutment forNobelActive 3.0(K151039) | Dentsply SironaATLANTIS™ Abutment forHIOSSEN ET implant(K160626) | Dentsply SironaATLANTIS™ Abutment forCONELOG implant(K161030) | Dentsply SironaATLANTIS™ Abutment for MISimplant(K172225) | Summary of Differences |
| Material | ||||||
| Titanium alloy | Titanium alloy, YttriaStabilized Zirconia | Titanium alloy | Titanium alloy, YttriaStabilized Zirconia | Titanium alloy | Titanium alloy, Zirconia | No difference. The proposedATLANTIS® Conus Structure isavailable only in titanium alloymaterial. The reference devices areavailable in the same titanium alloymaterial (although they are milledrather than fabricated by additivemanufacturing), but are also availablein zirconia ceramic material in somecases as noted. |
{11}------------------------------------------------
§ 872.3630 Endosseous dental implant abutment.
(a)
Identification. An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)